Overview
g.tec medical engineering is an Austrian company producing high-performance biosignal acquisition systems, BCI software, and neurostimulation equipment used in research hospitals and academic neuroscience labs worldwide. Their g.USBamp and g.Nautilus systems are gold standards in BCI and EEG research.
g.tec medical engineering is an Austrian neurotechnology company specializing in the development and manufacture of high-performance biosignal acquisition systems, brain-computer interface software, and neurostimulation equipment. Founded and headquartered in Schiedlberg, Austria, the company serves research hospitals, academic neuroscience laboratories, and clinical institutions across the globe. Their product portfolio includes the g.USBamp and g.Nautilus systems, which have become widely recognized gold standards in EEG and BCI research for their signal fidelity, reliability, and versatility. The company's integrated hardware and software ecosystem enables researchers to design, implement, and deploy complex neuroscientific experiments with a high degree of precision and reproducibility.
g.tec occupies a strong and well-established position within the research tools segment of the neurotechnology market, having built its reputation over decades of consistent innovation and close collaboration with leading scientific institutions worldwide. The company's systems have been deployed in hundreds of peer-reviewed studies, lending significant credibility to their platforms as foundational infrastructure for advancing brain-computer interface science. g.tec has also made notable strides in applying its technology to clinical rehabilitation contexts, including work on restoring communication and motor function in patients with severe neurological conditions such as ALS and spinal cord injury. As a privately held company, g.tec has maintained an independent growth trajectory driven by scientific merit and deep domain expertise rather than external investment cycles.
g.tec medical engineering represents a critical piece of the neurotechnology ecosystem precisely because its tools underpin a substantial portion of the field's foundational research. The reliability and performance of their acquisition systems mean that discoveries made using g.tec hardware carry a higher degree of scientific trustworthiness and cross-laboratory reproducibility. By bridging the gap between laboratory-grade research instrumentation and early-stage clinical application, g.tec has helped accelerate the translation of BCI science from theoretical concepts into tangible therapeutic tools. Their continued presence as an independent, innovation-focused company provides the broader neurotech industry with a stable and technically rigorous hardware foundation upon which next-generation brain-computer interface applications can be built.
More in Research Tools
Latest industry news
Synchron Closes $275M Series D to Accelerate Stentrode BCI Commercialization
2026-06-15 · Funding
MIT Researchers Demonstrate Real-Time Emotion Decoding via Non-Invasive EEG with 94% Accuracy
2026-06-13 · Research
Synchron Launches Stentrode Home Edition, Expanding BCI Access Beyond Clinical Settings
2026-06-11 · Product
Synchron Reaches 100-Patient Milestone as Stentrode BCI Moves Toward Pivotal Trial
2026-06-09 · Industry
Company details
Category
🔭 Research Tools
Location
Schiedlberg, Austria
Funding
Private
Website
www.gtec.atListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →